Member Info for AB124

Thanks Bermuda for the Trinity Delta heads-up. Even a scientifically challenged investor such as myself can use this input to obtain a balanced view of Scancell's prospects post the last RNS.
Encouraging.
I like that.
AIMO

Cleaner,
What prices were you working on derived from what sized enquiries?
Try using 20K size dummies to get a feel for real world pricing.

RW
What you concluded in your 20.27 is inaccurate and irrelevant.
Thanks for trying though.
:-)

Dragon,
Agree.
Very much along the lines of who knows what Scancell's success will be in each of their platforms? I'm pleased the Company is prepared to wait until the trials produce their data rather than over promising and under delivering.
Perhaps there's a message in there somewhere.
AIMO

Rw,
No I don't.
I posted,
"Why hasn't the SP shot up to 26p as Wild asked? In my view because Scancell didn't over promise, the BB did (maybe matching what the Market thought - and continues potentially to do so).
All best

TF
Firstly I am quite happy but kind of you to keep telling me to cheer up. :-)
As to the Covidity sell off, although it might have been the Company's stated strategy, I think the best case would have been against a backdrop of showing that Covidity was going to be a world beater which due to the vagaries of the SA trial has not been shown to be the case. That said it is not going to be taken forward by Scancell and so is hoped to be sold on. Since this is not being sold from the World beating basis and although we can say that it doesn't actually harm anyone there's a bit of a difference from the way it has been presented on this BB as being the answer to all things Covid. There's no clamour so far (or seemingly Big Pharma queuing up to hold an auction) so to many holders here today's RNS will have been a disappointment.
That said, it's just another ratchet down of the hype we've read for every Scancell Platform for years, and it is a recurring feature of the Scancell story.
If I question where the blame lies for over promising and under delivering I can't hold Scancell to task for it, because they never have done that. It's always been done for them and today's RNS is another case in point.
Why hasn't the SP shot up to 26p as Wild asked? In my view because Scancell didn't over promise, the BB did (maybe matching what the Market thought - and continues potentially to do so).
Viz From earlier today

"....may I suggest any one of the top 5 covid vaccine players can not afford to overlook a covid vaccine of this calibre /
they all understand the benefits of the oncology platforms
so maybe Biontech cant afford Scancell ?
the race is open because Covidity knocks the ball out of the park ?
interesting times"

Let's hope we can get something significant for Covidity, but it's not really got the sizzle of a world beater on the results so far, has it? The trial reported never was meant to show that anyway. if it was felt to be practical to collect the data to move out of the basic safety area perhaps that could be achieved but we're not going to do that are we?
Hence IMO that's the reason the market perceived Scancell shares to have been worth more a few trading days ago than it is now.
Another assessment from this BB in December last year,
"so if covidity results are positive and the suggested partnership arrives this will provide a rather nice boost to the SP. For me a key finding will be the side effects. So many are complaining of being knocked by the recent booster. Of course the hope is that Covidity will enable the world to be ahead of the virus and not behind the curve as we currently are. Lets just say the china crisis could be rather good timing for the sentiment for our SP. Of course this brings 2 benefits. Hopefully some cash to fund our vaccine development and AVidimab and our a higher SP for the launchpad as moditope develops."
We've still got some more data to wait for from other platforms so hopefully that might help

Wildforce,
"I do wonder how scancell was worth around 30% more a few trading days ago lol !"
Because investors were still fixated on the idea that there would be an announcement of a deal to sell off Covidity. Since nothing of the sort has so far been announced the SP hasn't staggered back to the highs you mentioned.
So the next thing for those interested to do is to tell the world that there will be a massive SP benefit from Scancell selling off Covidity for tons of dosh and then the SP will rise in anticipation.
Yep, that should do the trick.
AIMO

TF,
I'm perfectly happy about the fact that the platform's validated and that is very good news indeed for Scancell.
What I do find sad is the fact that there are many here who profess to be Scancell "Fans" but with their incessant overhyping of the platforms turn what should be a major milestone in the Scancell journey (Validation) into a bit of an anticlimax because they've raised expectations beyond reasonable (and scientifically sensible) levels.
This news should have been a major SP enhancing statement, but due to constant overhype is not the earth shattering news it might have been.
I wonder why Scancell keep their Corporate mouth shut until the have the RESULTS to prove their products rather than rush out PR which might not happen?
AIMO

Hang on. Covidity was being "hawked" in here as a world beating vaccine possibly to be taken forward by Scancell which would pass billions into the Company's coffers all on its own. The December RNS put that rather ambitious concept to bed and now there's a clever spin emerging that completely ignores all the earlier hype and moves it from billions to, " could still be dealable". Please let's not try and suggest that this is the outcome that even Crumbs was suggesting with big potential positives through the last couple of years. OK the product still has potential value but it ain't the panacea that many had suggested and that RNS in December softening the ground for the less than euphoric landing that's happened should not be spun as the "success" that now seems to be the case when there has been talk on this BB of a world dominating vaccine that was somehow being smothered at birth by the Pandemic profiteers. Of course there are positives for the platform as a whole but not to the extent that many had predicted.
I want Scancell to succeed but please, let's at least be honest with ourselves
AIMO.

C7
Ref your 15.01 thank you .
As to the whole sorry mess perhaps rather than raking it all up again and inflict even more pointless exchanges here it would be better to let the matter drop and wait for the official Trial updates from Scancell as and when they arrive.
AIMO.

Thanks for the responses.
I do understand the point that if posted on a public forum that the information is available to all,
BUT
to me it's a question of the original forum poster's intention.
I very much doubt many (if not all) would have imagined that their posts would be reposted on Twitter and that further discussions about their very personal situation would be continued.
FWIW I would have no problem whatsoever with discovering (and sharing) information about a Company that had been treated insecurely. The Forums re patients and their personal situations falls far short of poor Company management and is in a different class of "research" for me I'm afraid.
So accepting that other views are available, I'll leave it here. But the replies were sufficiently measured and reasonable to make me think a response was OK.
AIMO

Since the details from last year were published on a forum for the use of people suffering from (and in some cases being treated) for a diversity of oncological issues, maybe those who discovered their treatment and results being transported to a wider Social Media audience have simply set up a private group where their hopes, fears and results will be restricted to those who are personally involved. That is rather than being left to the (lack of) mercy displayed by some over intrusive financially motivated investors. That will allow Companies such as Scancell who are running such Trials to obtain, assess the Data and then Publish that information anonymously when such information is statistically significant.
Actually, I do hope that is the case.
We can wait, many can't.
AIMO

MaxParker
"“Under promise and over deliver”"
An excellent Maxim, sadly not echoed by LSE Posters over the years either.
If we wait all will be (eventually?) revealed.
If we try to second guess/predict outcomes at Scancell we are destined for disappointment.
Why?
Because Scancell have all the information but even they can't keep to their own timelines.
If that's the case how can lay posters on a BB do better?
If they could (and they haven't to date) that would be a VERY serious indictment of the Scancell BOD.
Patience seems to be the requirement here.
AIMO

Can't argue against it... We simply don't know.

Data has been the most important commodity for Scancell since 2012.
Let's hope we get a break in the surfeit of lack of Data sometiime soon.
It's as simple as we'll get any information when Scancell decide they have it want to release it and nothing we post here will make any difference to that.
It's the story of Scancell for the last eleven years, nothing new.
AIMO

Perhaps we could create a template for this thread?
Pull it up and fillet in.
In the meantime I hear SP projections amended to
sick squid?
No more now, I promise.

So sorry for the duplication.... Showed up as unsent from earlier on my phone. I'm fin ished on this now...

They're desperately floundering around for information but being taken in hook line and sinker.
Better to wait for Scancell to announce developments?
:-)

They're desperately floundering around for information but being taken in hook line and sinker.
Better to wait for Scancell to announce developments?
:-)

Chelsea11
All part of the investment process. Research the company, buy the shares wait for the anticipated return. That return may be cashflow through dividend payments or maybe through capital via a takeover or maybe a mixture of the two.
Generally speaking if an investor decides on buying shares he/she watched for information and progress in the business via company reporting and then the only decision really required is whether to remain invested. Obviously investors buy shares to get returns so the expectations of capital appreciation and income growth are always there. In a diversified portfolio an investor Will keep a weather eye on holdings with regular reassessments but with a list of say ten or fifteen different shareholdings it would be crazy to look every day at every holding. If the investor is confident of his original and ongoing faith in the company he can sit back and wait for the fruits of his (research) labours to be forthcoming. He doesn't need to reassure himself every day that he's got it right. He should have faith that his judgement in buying is sound.
So unless there's evidence that the original assessment was flawed, the shares can be held with confidence for the future allowing the holder to live life without worrying about every small setback or price rise.
Equity investment is essentially medium to long term, without the need for daily reassurance. Life should be enhanced by successful investments. Not driven by them.
AIMO